Search studies

61 studies found

APPROACH source cohorts

All baseline cohort parameters, clinical, conventional (knee x-ray and MRI and the robust biochemical markers), and novel markers (T2 relaxation MRI for cartilage collagen distribution, gagCEST MRI cartilage for proteoglycan content, knee CT/x-ray for bone shape and trabecular architecture, knee motion, and novel biochemical markers describing turnover of specific tissue component, as well as involvement of hand, hip and spine joint damage, hand joint inflammation, hip motion and shape and bo...

Types Observational Biomarker Validation And Qualification
dc9a475c-147a-11eb-b51f-8c8590c45a21

BIOMAP

Aggregation of all BIOMAP cohorts

Types Biomarker Discovery
b70ca060-813e-11ed-9414-acde48001122

CARE

Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity

Types Clinical Trial Target Identification Drug Discovery Drug Repurposing
532cda6a-ee0a-11eb-920d-acde48001122

DIRECT

Interim analysis. Study outline is available in Diabetologia (2014) 57:1132–1142.

Types Observational
dc9ae590-147a-11eb-b51f-8c8590c45a21

EBiSC study

The European Bank for induced pluripotent Stem Cells (EBiSC) is a centralised, not-for-profit iPSC bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality tools for new medicines development.

Types Induced Pluripotent Stem Cells
ef8de6f2-51c4-11eb-89dd-acde48001122

EBiSC2 study

The European Bank for induced pluripotent Stem Cells (EBiSC) is a centralised, not-for-profit iPSC bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality tools for new medicines development.

Types Induced Pluripotent Stem Cells
670afece-2432-11eb-8464-acde48001122